HeartWare Ventricular Assist System (HVAD). Catalog #'s US: 1101 and 1103 / OUS: 1100, 1101,1102...
FDA Device Recall #Z-1698-2015 — Class I — April 29, 2015
Recall Summary
| Recall Number | Z-1698-2015 |
| Classification | Class I — Serious risk |
| Date Initiated | April 29, 2015 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | HeartWare Inc |
| Location | Miami Lakes, FL |
| Product Type | Devices |
| Quantity | 3,747 currently implanted worldwide |
Product Description
HeartWare Ventricular Assist System (HVAD). Catalog #'s US: 1101 and 1103 / OUS: 1100, 1101,1102,1104,1104JP and 1205. Product Usage: For use as a bridge-to-cardiac transplantation in patient who are at risk of death from refractory end-stage left ventricular heart failure.
Reason for Recall
HeartWare has received complaints relating to damage or bent connection pins within the power supply ports of the VAD controller.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, IL, IN, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NY, OH, OR, PA, SC, TN, TX, UT, VA and countries of Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Croatia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Japan, Korea, Lebanon, Lithuania, Luxembourg, Malaysia, Netherlands, New Zealand, Norway, Poland, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Turkey, and UK.
Lot / Code Information
Serial #: ALL HeartWare HVAD systems currently in use.
Other Recalls from HeartWare Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1751-2015 | Class II | HeartWare Ventricular Assist System (HVAD) For ... | Apr 29, 2015 |
| Z-1726-2015 | Class I | HeartWare Ventricular Assist System (HVAD). Ca... | Apr 29, 2015 |
| Z-1731-2015 | Class I | HeartWare Ventricular Assist System (HVAD). ... | Apr 29, 2015 |
| Z-1917-2015 | Class II | HeartWare Ventricular Assist System (HVAD) For... | Apr 29, 2015 |
| Z-1604-2015 | Class I | HeartWare Ventricular Assist System (HVAD) Pump... | Apr 29, 2015 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.